Tue, 17 Apr 2018 09:33:08 GMT
Sanofi considers selling generics arm for $2.4B
France's healthcare group Sanofi is in negotiations to sell its EU generics drugs arm Zentiva to Advent International, the US private equity firm, for $2.4B, the companies announced on Tuesday.